References
- CoyneKSSextonCCVatsVThompsonCKoppZSMilsomINational community prevalence of overactive bladder in the United States stratified by sex and ageUrology20117751081108721256571
- AbramsPCardozoLFallMThe standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence SocietyUrology2003611374912559262
- AbramsPKelleherCJKerrLARogersRGOveractive bladder significantly affects quality of lifeAm J Manag Care2000611 SupplS580S59011183901
- HelfandBTEvansRMMcvaryKTA comparison of the frequencies of medical therapies for overactive bladder in men and women: analysis of more than 7.2 million aging patientsEur Urol201057458659120036783
- DrutzHPOveractive bladder: the importance of tailoring treatment to the individual patientJ Multidiscip Healthc2011423323721847345
- SwinburnPLloydAAliSHashmiNNewalDNajibHPreferences for antimuscarinic therapy for overactive bladderBJU Int2011108686887321105989
- HeisenMBaetenSAVerheggenBGPatient and physician preferences for oral pharmacotherapy for overactive bladder: two discrete choice experimentsCurr Med Res Opin201632478779626789823
- DecalfVHHuionAMJBenoitDFDenysMAPetrovicMEveraertKOlder People’s Preferences for Side Effects Associated with Antimuscarinic Treatments of Overactive Bladder: A Discrete-Choice ExperimentDrugs Aging201734861562328656509
- YangJ-CJohnsonFRKilambiVMohamedAFSample size and utility-difference precision in discrete-choice experiments: A meta-simulation approachJournal of Choice Modelling2015165057
- HallSALinkCLHuJCEggersPWMckinlayJBDrug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sampleBJU Int2009104111680168819549122
- Reed JohnsonFLancsarEMarshallDConstructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task ForceValue Health201316131323337210
- CoyneKSThompsonCLLaiJSSextonCCAn overactive bladder symptom and health-related quality of life short-form: validation of the OAB-q SFNeurourol Urodyn201534325526325783168
- PiaultEEvansCJEspindleDKoppZBrubakerLAbramsPDevelopment and validation of the Overactive Bladder Satisfaction (OAB-S) QuestionnaireNeurourol Urodyn200827317919017565727
- MckinlayJBLinkCLMeasuring the urologic iceberg: design and implementation of the Boston Area Community Health (BACH) SurveyEur Urol200752238939617383808
- MorleyJEMalmstromTKMillerDKA simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African AmericansJ Nutr Health Aging201216760160822836700
- ReillyMCZbrozekASDukesEMThe validity and reproducibility of a work productivity and activity impairment instrumentPharmacoeconomics19934535336510146874
- HuberJZwerinaKThe Importance of Utility Balance in Efficient Choice DesignsJournal of Marketing Research1996333307317
- KuhfeldWFTobiasRDGarrattMEfficient Experimental Design with Marketing Research ApplicationsJournal of Marketing Research1994314545264
- KuhfeldWFMarketing Research Methods in SAS: Experimental Design, Choice, Conjoint, and Graphical Techniques2010 Available from: http://support.sas.com/techsup/technote/mr2010.pdfAccessed December 1, 2017
- HauberABGonzálezJMGroothuis-OudshoornCGStatistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task ForceValue Health201619430031527325321
- WuJMFultonRGAmundsenCLKnightSKKuppermannMPatient preferences for different severities of and treatments for overactive bladderFemale Pelvic Med Reconstr Surg201117418418922453849